**Core Concept**
The cell cycle is a tightly regulated process that ensures proper cell division and growth. Key regulators of the cell cycle include cyclin-dependent kinases (CDKs) and their inhibitors, which play critical roles in controlling the transition between different phases of the cell cycle. Dysregulation of these regulators is a common feature in various human cancers.

**Why the Correct Answer is Right**
P21, also known as cyclin-dependent kinase inhibitor 1 (CDKN1A), is a tumor suppressor protein that inhibits CDKs and prevents cell cycle progression. While P21 is involved in the cell cycle, its primary function is not as a key regulator of the cell cycle, unlike the other options. P21 is often induced in response to DNA damage and acts as a checkpoint to prevent cell cycle progression, allowing time for DNA repair. In contrast, the other options are critical cell cycle regulators that are frequently dysregulated in cancer. P16/INK4a and RB (retinoblastoma protein) are tumor suppressors that inhibit CDKs and prevent cell cycle progression, while Cyclin D is an oncogene that promotes cell cycle progression.

**Why Each Wrong Option is Incorrect**
**Option A:** P16/INK4a is a tumor suppressor that inhibits CDK4 and CDK6, preventing phosphorylation of RB and subsequent cell cycle progression. Its dysregulation is a common feature in various human cancers, including melanoma and pancreatic cancer.

**Option B:** Cyclin D is an oncogene that promotes cell cycle progression by binding to and activating CDK4 and CDK6. Its overexpression is associated with several types of cancer, including breast cancer and ovarian cancer.

**Option D:** RB is a tumor suppressor that inhibits cell cycle progression by binding to E2F transcription factors. Its dysregulation is a common feature in various human cancers, including retinoblastoma and osteosarcoma.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that the cell cycle is a tightly regulated process, and dysregulation of key regulators is a common feature in various human cancers. Understanding the role of these regulators and their interactions is crucial for developing effective cancer therapies.

**✓ Correct Answer: C. P21**